0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Animal Model for Drug Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-8L6461
Home | Market Reports | Health| Health Foundations & Medical Research
Global Animal Model for Drug Testing Market Research Report 2021
BUY CHAPTERS

Animal Model for Drug Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8L6461
Report
October 2024
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal Model for Drug Testing - Market Size

The global market for Animal Model for Drug Testing was estimated to be worth US$ 2350 million in 2023 and is forecast to a readjusted size of US$ 3422.1 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Animal Model for Drug Testing - Market

Animal Model for Drug Testing - Market

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
In our report, all the animals used in scientific purposes are included.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 29%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal Model for Drug Testing, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Animal Model for Drug Testing by region & country, by Type, and by Application.
The Animal Model for Drug Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Model for Drug Testing.
Market Segmentation

Scope of Animal Model for Drug Testing - Market Report

Report Metric Details
Report Name Animal Model for Drug Testing - Market
Forecasted market size in 2030 US$ 3422.1 million
CAGR 5.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Rats
  • Mice
  • Others
Segment by Application
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Shangghai Modelorg, GenOway, Syngene International, Psychogenics, Pharmaron, Pharmalegacy, Vitalstar Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Animal Model for Drug Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Animal Model for Drug Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Animal Model for Drug Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Animal Model for Drug Testing - Market size in 2030?

Ans: The Animal Model for Drug Testing - Market size in 2030 will be US$ 3422.1 million.

What is the Animal Model for Drug Testing - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Animal Model for Drug Testing - Market report?

Ans: The main players in the Animal Model for Drug Testing - Market are Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Shangghai Modelorg, GenOway, Syngene International, Psychogenics, Pharmaron, Pharmalegacy, Vitalstar Biotechnology

What are the Application segmentation covered in the Animal Model for Drug Testing - Market report?

Ans: The Applications covered in the Animal Model for Drug Testing - Market report are Academic and Research Institutes, Pharmaceutical and Biotechnology Companies

What are the Type segmentation covered in the Animal Model for Drug Testing - Market report?

Ans: The Types covered in the Animal Model for Drug Testing - Market report are Rats, Mice, Others

1 Market Overview
1.1 Animal Model for Drug Testing Product Introduction
1.2 Global Animal Model for Drug Testing Market Size Forecast
1.2.1 Global Animal Model for Drug Testing Sales Value (2019-2030)
1.2.2 Global Animal Model for Drug Testing Sales Volume (2019-2030)
1.2.3 Global Animal Model for Drug Testing Sales Price (2019-2030)
1.3 Animal Model for Drug Testing Market Trends & Drivers
1.3.1 Animal Model for Drug Testing Industry Trends
1.3.2 Animal Model for Drug Testing Market Drivers & Opportunity
1.3.3 Animal Model for Drug Testing Market Challenges
1.3.4 Animal Model for Drug Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Model for Drug Testing Players Revenue Ranking (2023)
2.2 Global Animal Model for Drug Testing Revenue by Company (2019-2024)
2.3 Global Animal Model for Drug Testing Players Sales Volume Ranking (2023)
2.4 Global Animal Model for Drug Testing Sales Volume by Company Players (2019-2024)
2.5 Global Animal Model for Drug Testing Average Price by Company (2019-2024)
2.6 Key Manufacturers Animal Model for Drug Testing Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Animal Model for Drug Testing Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Animal Model for Drug Testing
2.9 Animal Model for Drug Testing Market Competitive Analysis
2.9.1 Animal Model for Drug Testing Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Animal Model for Drug Testing Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Model for Drug Testing as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rats
3.1.2 Mice
3.1.3 Others
3.2 Global Animal Model for Drug Testing Sales Value by Type
3.2.1 Global Animal Model for Drug Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal Model for Drug Testing Sales Value, by Type (2019-2030)
3.2.3 Global Animal Model for Drug Testing Sales Value, by Type (%) (2019-2030)
3.3 Global Animal Model for Drug Testing Sales Volume by Type
3.3.1 Global Animal Model for Drug Testing Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Animal Model for Drug Testing Sales Volume, by Type (2019-2030)
3.3.3 Global Animal Model for Drug Testing Sales Volume, by Type (%) (2019-2030)
3.4 Global Animal Model for Drug Testing Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic and Research Institutes
4.1.2 Pharmaceutical and Biotechnology Companies
4.2 Global Animal Model for Drug Testing Sales Value by Application
4.2.1 Global Animal Model for Drug Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal Model for Drug Testing Sales Value, by Application (2019-2030)
4.2.3 Global Animal Model for Drug Testing Sales Value, by Application (%) (2019-2030)
4.3 Global Animal Model for Drug Testing Sales Volume by Application
4.3.1 Global Animal Model for Drug Testing Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Animal Model for Drug Testing Sales Volume, by Application (2019-2030)
4.3.3 Global Animal Model for Drug Testing Sales Volume, by Application (%) (2019-2030)
4.4 Global Animal Model for Drug Testing Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Animal Model for Drug Testing Sales Value by Region
5.1.1 Global Animal Model for Drug Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal Model for Drug Testing Sales Value by Region (2019-2024)
5.1.3 Global Animal Model for Drug Testing Sales Value by Region (2025-2030)
5.1.4 Global Animal Model for Drug Testing Sales Value by Region (%), (2019-2030)
5.2 Global Animal Model for Drug Testing Sales Volume by Region
5.2.1 Global Animal Model for Drug Testing Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Animal Model for Drug Testing Sales Volume by Region (2019-2024)
5.2.3 Global Animal Model for Drug Testing Sales Volume by Region (2025-2030)
5.2.4 Global Animal Model for Drug Testing Sales Volume by Region (%), (2019-2030)
5.3 Global Animal Model for Drug Testing Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Animal Model for Drug Testing Sales Value, 2019-2030
5.4.2 North America Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Animal Model for Drug Testing Sales Value, 2019-2030
5.5.2 Europe Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Animal Model for Drug Testing Sales Value, 2019-2030
5.6.2 Asia Pacific Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Animal Model for Drug Testing Sales Value, 2019-2030
5.7.2 South America Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Animal Model for Drug Testing Sales Value, 2019-2030
5.8.2 Middle East & Africa Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Model for Drug Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal Model for Drug Testing Sales Value
6.2.1 Key Countries/Regions Animal Model for Drug Testing Sales Value, 2019-2030
6.2.2 Key Countries/Regions Animal Model for Drug Testing Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Animal Model for Drug Testing Sales Value, 2019-2030
6.3.2 United States Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal Model for Drug Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal Model for Drug Testing Sales Value, 2019-2030
6.4.2 Europe Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal Model for Drug Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal Model for Drug Testing Sales Value, 2019-2030
6.5.2 China Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal Model for Drug Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal Model for Drug Testing Sales Value, 2019-2030
6.6.2 Japan Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal Model for Drug Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal Model for Drug Testing Sales Value, 2019-2030
6.7.2 South Korea Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal Model for Drug Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Model for Drug Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal Model for Drug Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal Model for Drug Testing Sales Value, 2019-2030
6.9.2 India Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal Model for Drug Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Company Information
7.1.2 Charles River Laboratories Introduction and Business Overview
7.1.3 Charles River Laboratories Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Charles River Laboratories Animal Model for Drug Testing Product Offerings
7.1.5 Charles River Laboratories Recent Development
7.2 Envigo
7.2.1 Envigo Company Information
7.2.2 Envigo Introduction and Business Overview
7.2.3 Envigo Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Envigo Animal Model for Drug Testing Product Offerings
7.2.5 Envigo Recent Development
7.3 Taconic Biosciences
7.3.1 Taconic Biosciences Company Information
7.3.2 Taconic Biosciences Introduction and Business Overview
7.3.3 Taconic Biosciences Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Taconic Biosciences Animal Model for Drug Testing Product Offerings
7.3.5 Taconic Biosciences Recent Development
7.4 Jackson Laboratory
7.4.1 Jackson Laboratory Company Information
7.4.2 Jackson Laboratory Introduction and Business Overview
7.4.3 Jackson Laboratory Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Jackson Laboratory Animal Model for Drug Testing Product Offerings
7.4.5 Jackson Laboratory Recent Development
7.5 Crown Biosciences
7.5.1 Crown Biosciences Company Information
7.5.2 Crown Biosciences Introduction and Business Overview
7.5.3 Crown Biosciences Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Crown Biosciences Animal Model for Drug Testing Product Offerings
7.5.5 Crown Biosciences Recent Development
7.6 Shanghai SLAC
7.6.1 Shanghai SLAC Company Information
7.6.2 Shanghai SLAC Introduction and Business Overview
7.6.3 Shanghai SLAC Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Shanghai SLAC Animal Model for Drug Testing Product Offerings
7.6.5 Shanghai SLAC Recent Development
7.7 Shangghai Modelorg
7.7.1 Shangghai Modelorg Company Information
7.7.2 Shangghai Modelorg Introduction and Business Overview
7.7.3 Shangghai Modelorg Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Shangghai Modelorg Animal Model for Drug Testing Product Offerings
7.7.5 Shangghai Modelorg Recent Development
7.8 GenOway
7.8.1 GenOway Company Information
7.8.2 GenOway Introduction and Business Overview
7.8.3 GenOway Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.8.4 GenOway Animal Model for Drug Testing Product Offerings
7.8.5 GenOway Recent Development
7.9 Syngene International
7.9.1 Syngene International Company Information
7.9.2 Syngene International Introduction and Business Overview
7.9.3 Syngene International Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Syngene International Animal Model for Drug Testing Product Offerings
7.9.5 Syngene International Recent Development
7.10 Psychogenics
7.10.1 Psychogenics Company Information
7.10.2 Psychogenics Introduction and Business Overview
7.10.3 Psychogenics Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Psychogenics Animal Model for Drug Testing Product Offerings
7.10.5 Psychogenics Recent Development
7.11 Pharmaron
7.11.1 Pharmaron Company Information
7.11.2 Pharmaron Introduction and Business Overview
7.11.3 Pharmaron Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Pharmaron Animal Model for Drug Testing Product Offerings
7.11.5 Pharmaron Recent Development
7.12 Pharmalegacy
7.12.1 Pharmalegacy Company Information
7.12.2 Pharmalegacy Introduction and Business Overview
7.12.3 Pharmalegacy Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Pharmalegacy Animal Model for Drug Testing Product Offerings
7.12.5 Pharmalegacy Recent Development
7.13 Vitalstar Biotechnology
7.13.1 Vitalstar Biotechnology Company Information
7.13.2 Vitalstar Biotechnology Introduction and Business Overview
7.13.3 Vitalstar Biotechnology Animal Model for Drug Testing Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Vitalstar Biotechnology Animal Model for Drug Testing Product Offerings
7.13.5 Vitalstar Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Animal Model for Drug Testing Industrial Chain
8.2 Animal Model for Drug Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Model for Drug Testing Sales Model
8.5.2 Sales Channel
8.5.3 Animal Model for Drug Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Animal Model for Drug Testing Market Trends
    Table 2. Animal Model for Drug Testing Market Drivers & Opportunity
    Table 3. Animal Model for Drug Testing Market Challenges
    Table 4. Animal Model for Drug Testing Market Restraints
    Table 5. Global Animal Model for Drug Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Animal Model for Drug Testing Revenue Market Share by Company (2019-2024)
    Table 7. Global Animal Model for Drug Testing Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Animal Model for Drug Testing Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Animal Model for Drug Testing Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Animal Model for Drug Testing Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Animal Model for Drug Testing Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Animal Model for Drug Testing
    Table 13. Global Animal Model for Drug Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Model for Drug Testing as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Animal Model for Drug Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Animal Model for Drug Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Animal Model for Drug Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Animal Model for Drug Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Animal Model for Drug Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Animal Model for Drug Testing Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Animal Model for Drug Testing Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Animal Model for Drug Testing Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Animal Model for Drug Testing Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Animal Model for Drug Testing Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Animal Model for Drug Testing Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Animal Model for Drug Testing Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Animal Model for Drug Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Animal Model for Drug Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Animal Model for Drug Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Animal Model for Drug Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Animal Model for Drug Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Animal Model for Drug Testing Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Animal Model for Drug Testing Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Animal Model for Drug Testing Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Animal Model for Drug Testing Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Animal Model for Drug Testing Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Animal Model for Drug Testing Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Animal Model for Drug Testing Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Animal Model for Drug Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Animal Model for Drug Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Animal Model for Drug Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Animal Model for Drug Testing Sales Value by Region (2019-2024) & (%)
    Table 44. Global Animal Model for Drug Testing Sales Value by Region (2025-2030) & (%)
    Table 45. Global Animal Model for Drug Testing Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Animal Model for Drug Testing Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Animal Model for Drug Testing Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Animal Model for Drug Testing Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Animal Model for Drug Testing Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Animal Model for Drug Testing Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Animal Model for Drug Testing Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Animal Model for Drug Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Animal Model for Drug Testing Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Animal Model for Drug Testing Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Animal Model for Drug Testing Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Animal Model for Drug Testing Sales Volume, (2025-2030) & (K Units)
    Table 57. Charles River Laboratories Company Information
    Table 58. Charles River Laboratories Introduction and Business Overview
    Table 59. Charles River Laboratories Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Charles River Laboratories Animal Model for Drug Testing Product Offerings
    Table 61. Charles River Laboratories Recent Development
    Table 62. Envigo Company Information
    Table 63. Envigo Introduction and Business Overview
    Table 64. Envigo Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Envigo Animal Model for Drug Testing Product Offerings
    Table 66. Envigo Recent Development
    Table 67. Taconic Biosciences Company Information
    Table 68. Taconic Biosciences Introduction and Business Overview
    Table 69. Taconic Biosciences Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Taconic Biosciences Animal Model for Drug Testing Product Offerings
    Table 71. Taconic Biosciences Recent Development
    Table 72. Jackson Laboratory Company Information
    Table 73. Jackson Laboratory Introduction and Business Overview
    Table 74. Jackson Laboratory Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Jackson Laboratory Animal Model for Drug Testing Product Offerings
    Table 76. Jackson Laboratory Recent Development
    Table 77. Crown Biosciences Company Information
    Table 78. Crown Biosciences Introduction and Business Overview
    Table 79. Crown Biosciences Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Crown Biosciences Animal Model for Drug Testing Product Offerings
    Table 81. Crown Biosciences Recent Development
    Table 82. Shanghai SLAC Company Information
    Table 83. Shanghai SLAC Introduction and Business Overview
    Table 84. Shanghai SLAC Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Shanghai SLAC Animal Model for Drug Testing Product Offerings
    Table 86. Shanghai SLAC Recent Development
    Table 87. Shangghai Modelorg Company Information
    Table 88. Shangghai Modelorg Introduction and Business Overview
    Table 89. Shangghai Modelorg Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Shangghai Modelorg Animal Model for Drug Testing Product Offerings
    Table 91. Shangghai Modelorg Recent Development
    Table 92. GenOway Company Information
    Table 93. GenOway Introduction and Business Overview
    Table 94. GenOway Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. GenOway Animal Model for Drug Testing Product Offerings
    Table 96. GenOway Recent Development
    Table 97. Syngene International Company Information
    Table 98. Syngene International Introduction and Business Overview
    Table 99. Syngene International Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Syngene International Animal Model for Drug Testing Product Offerings
    Table 101. Syngene International Recent Development
    Table 102. Psychogenics Company Information
    Table 103. Psychogenics Introduction and Business Overview
    Table 104. Psychogenics Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Psychogenics Animal Model for Drug Testing Product Offerings
    Table 106. Psychogenics Recent Development
    Table 107. Pharmaron Company Information
    Table 108. Pharmaron Introduction and Business Overview
    Table 109. Pharmaron Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Pharmaron Animal Model for Drug Testing Product Offerings
    Table 111. Pharmaron Recent Development
    Table 112. Pharmalegacy Company Information
    Table 113. Pharmalegacy Introduction and Business Overview
    Table 114. Pharmalegacy Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Pharmalegacy Animal Model for Drug Testing Product Offerings
    Table 116. Pharmalegacy Recent Development
    Table 117. Vitalstar Biotechnology Company Information
    Table 118. Vitalstar Biotechnology Introduction and Business Overview
    Table 119. Vitalstar Biotechnology Animal Model for Drug Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Vitalstar Biotechnology Animal Model for Drug Testing Product Offerings
    Table 121. Vitalstar Biotechnology Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Animal Model for Drug Testing Downstream Customers
    Table 125. Animal Model for Drug Testing Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Animal Model for Drug Testing Product Picture
    Figure 2. Global Animal Model for Drug Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Animal Model for Drug Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Animal Model for Drug Testing Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Animal Model for Drug Testing Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Animal Model for Drug Testing Report Years Considered
    Figure 7. Global Animal Model for Drug Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Animal Model for Drug Testing Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Animal Model for Drug Testing Revenue in 2023
    Figure 10. Animal Model for Drug Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Rats Picture
    Figure 12. Mice Picture
    Figure 13. Others Picture
    Figure 14. Global Animal Model for Drug Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Animal Model for Drug Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Animal Model for Drug Testing Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Animal Model for Drug Testing Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Animal Model for Drug Testing Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Academic and Research Institutes
    Figure 20. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 21. Global Animal Model for Drug Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Animal Model for Drug Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Animal Model for Drug Testing Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Animal Model for Drug Testing Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Animal Model for Drug Testing Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Animal Model for Drug Testing Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Animal Model for Drug Testing Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Animal Model for Drug Testing Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Animal Model for Drug Testing Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Animal Model for Drug Testing Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Animal Model for Drug Testing Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Animal Model for Drug Testing Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Animal Model for Drug Testing Sales Volume (%), (2019-2030)
    Figure 38. United States Animal Model for Drug Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Animal Model for Drug Testing Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Animal Model for Drug Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Animal Model for Drug Testing Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Animal Model for Drug Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Animal Model for Drug Testing Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Animal Model for Drug Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Animal Model for Drug Testing Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Animal Model for Drug Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Animal Model for Drug Testing Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Animal Model for Drug Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Animal Model for Drug Testing Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Animal Model for Drug Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Animal Model for Drug Testing Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Animal Model for Drug Testing Sales Value by Application (%), 2023 VS 2030
    Figure 59. Animal Model for Drug Testing Industrial Chain
    Figure 60. Animal Model for Drug Testing Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS